Mouse/Rat FGF-23 ELISA Kit

Mouse/Rat FGF-23 ELISA Kit

参考价: 面议

具体成交价以合同协议为准
2023-09-25 07:50:05
2089
产品属性
关闭
北京科瑞美科技有限公司

北京科瑞美科技有限公司

免费会员11
收藏

组合推荐相似产品

产品简介

Mouse/Rat FGF-23 (C-Term)ELISA Kit is intended for research use only in the quantitative determination of Mouse FGF-23 levels in serum, plasma or cell culture media.

详细介绍

一.产品名称:

通用名称:大/小鼠成纤维细胞生长因子23 ELISA试剂盒

英文名称:Mouse/Rat FGF-23 ELISA Kit

二.Mouse FGF-23 ELISA介绍:

Mouse/Rat FGF-23 ELISA Kit is intended for research use only in the quantitative determination of Mouse FGF-23 levels in serum, plasma or cell culture media. This assay is also useful in the determination of Rat FGF-23 levels.
 

Fibroblast growth factor 23 (FGF-23) is a recently discovered, novel member of a large family of related proteins. Its gene encodes a 251 amino acid protein. The amino-terminal portion of FGF-23 (aa 1-24) is hydrophobic and is likely to serve as a signal peptide allowing its secretion into the blood circulation. Its carboxyl-terminal portion (aa 180-251) shares only limited amino acid homology with other members of the FGF family of proteins.


Renal phosphate wasting disorders leading to hypophosphatemia are among the causes of defective mineralization of bone and growth plate development. Autosomal dominant hypophosphatemic rickets (ADHR), a rare genetic disorder, results from one of several different FGF-23 mutations that make the protein resistant to proteolytic cleavage. Furthermore, tumors that cause oncogenic osteomalacia (OOM) have been shown to overexpress FGF-23 mRNA making it likely that elevated concentrations of FGF-23 in the blood are the cause of renal phosphate wasting. Consistent with this conclusion, the administration of recombinant FGF-23 to rodents was shown to increase urinary excretion of phosphate thus leading to hypophosphatemia and osteomalacia/rickets. Recent studies with chronic kidney disease (CKD) patients have shown FGF-23 to be an early predictor of abnormal renal tubular function, bone mineralization, disease progression and over-all mortality risk.


Taken together, all currently available data suggest that the measurement of FGF-23 levels may provide an important diagnostic tool for the evaluation of hypophosphatemic and hyperphosphatemic disorders.
 

如需了解更多产品,请北京科瑞美公司。

 

上一篇:卒中后认知障碍患者粪便钙卫蛋白测定及其与血清炎性因子的相关性 下一篇:德国IBL现货供应
热线电话 在线询价
提示

请选择您要拨打的电话:

当前客户在线交流已关闭
请电话联系他 :